Influence of Different {beta}-Blockers on Platelet Aggregation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy

Conclusion:
Patients with CAD on dual antiplatelet therapy who used nebivolol had significantly lower levels of residual ADP-induced platelet aggregation compared to baseline than patients who used bisoprolol.

Source: Journal of Cardiovascular Pharmacology and Therapeutics - December 10, 2015 Category: Cardiology Authors: Ignjatovic, V., Pavlovic, S., Miloradovic, V., Andjelkovic, N., Davidovic, G., Djurdjevic, P., Stolic, R., Iric-Cupic, V., Simic, I., Ignjatovic, V. D., Petrovic, N., Smiljanic, Z., Zdravkovic, V., Simovic, S., Jovanovic, D., Nesic, J. Tags: Clinical Studies Source Type: research